By Clinical Research News Staff

February 7, 2023 | A winner has been chosen for the 7th Annual Participant Engagement Award and was announced after a live presentation and judging session at the Summit for Clinical Ops Executives, on February 6, 2023, in Orlando, Fla. The finalists presented their concepts live to the SCOPE audience, followed by a question-and-answer session conducted by the judges.

The Participant Engagement Award recognizes innovation and change in how the clinical research industry communicates with participants in the fields of recruitment and retention in clinical trials. The award is given each year in memory of Jerry Matczak, the first winner in 2017.

2023 Participant Engagement Award Winner

StudyKIK: Leveraging Mobile Technology to Improve Engagement and Support Patients in Oncology Trials 

Participant Engagement Awards Runners-Up

1nHealth:  Have The Colon Conversation: An omni-channel digital outreach campaign to challenge older adults to get their first screening colonoscopy

ProofPilot: A Co-Pilot for Patients 

Participant Engagement Awards Finalists

Cedar Health Research: Diversity Enrollment Through Tech-Enabled Community Healthcare Partnerships 

ClinOne: Connecting HCPs (and Their Patients) to a Phase 3 Trial for Frontotemporal Dementia 

The Participant Engagement Awards program was created by David Sall, President & CEO, Patient Enrollment Advisors and Kelly McKee, Vice President, Decentralized Clinical Trials (DCT), Medidata. Along with Sall and McKee, the program’s judges include Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI); Gretchen Goller, Sr. Director, Head of Patient Recruitment, Clinical Development Operations, Seagen; Anne Marie Mercurio, clinical trial volunteer and patient advocate; Marisa Rackley, Vice President, Clinical Site Start Up, Site Engagement, Trial Optimization, Takeda; Kendal Whitlock, Head, Digital Optimization, RWE Clinical Trials, Walgreens Boots Alliance; Kelly White, Senior Director, Head, Global Trial Optimization, Oncology, Merck & Co; and Irena Webster, Vice President, Head of Development Operations, Forma Therapeutics.